Gene-therapy test launches pivotal year for precise genome-editing technique known as base editing
Credit: Martin Steinthaler/GettyA clinical trial that recently treated its first participant will test whether base-editing — a genome-editing method related to the CRISPR–Cas9 system — can safely be used to make precise, single-letter changes to a DNA sequence in a cholesterol-regulating gene without breaking both strands of DNA first, as CRISPR–Cas9 would do.
Both tests are expected to report results in 2023, and further base-editing treatments are working their way through the pipeline towards clinical trials. “It’s very exciting that the first clinical trials are starting, with CRISPR–Cas9 and now also with base editing,” says Gerald Schwank, who studies the use of genome editing to treat diseases at the University of Zurich, Switzerland. “We’ve got a lot to learn.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Arlo Go 2 or Eufy 4G Starlight: which is the best cellular security camera?We put two LTE smart security cameras to the test.
Read more »
Researchers grew a piece of the human heart, and it actually beatsResearchers have managed to grow a piece of a human heart that actually beats, opening new doors in the study of cardiovascular disease.
Read more »
CDC issues health network advisory as Parechovirus spreadsParechovirus is spreading across multiple states, according to the Centers for Disease Control and Prevention. News4JAX spoke with UF Health Chief of Infectious Disease, Dr. Mobeen Rathore about it.
Read more »
What a Good Night’s Sleep Can Do for Your HeartThe key to a healthier heart might be your sleep. New guidelines reflect a growing understanding of how sleep helps our hearts.
Read more »
Should You Wear White or Black on Hot Days? Here's the DataQuick experiments can help you answer the eternal question of whether to wear black or white on hot summer days. Turns out, it's complicated.
Read more »
Texan spreads awareness as she fights rare Pompe diseaseThe rare muscular disease affects about one in 22,000 Americans. One being Austinite Kelly Kelley, who isn't letting the illness stop her from living life to the fullest.
Read more »